Medical Device Investing Medtronic to announce financial results for its fourth quarter and full fiscal year 2025
Medical Device Investing New survey: 1 in 3 women have not talked to their doctor about heart health, the #1 killer of women
Medical Device Investing Medtronic Affera pulsed field ablation technologies continue to demonstrate promising evidence for atrial fibrillation patients
Medical Device Investing Medtronic Expand URO U.S. clinical trial meets safety and effectiveness primary endpoints for Hugo robotic-assisted surgery system
Medical Device Investing Medtronic receives FDA approval for smallest-diameter, lumenless defibrillation lead, the OmniaSecure lead and announces investigational clinical study results
Medical Device Investing Medtronic advances Abbott CGM partnership with FDA submission of interoperable insulin pump
Medical Device Investing Orchestra BioMed Announces AVIM Therapy-Focused Satellite Symposium at HRS 2025 Annual Meeting
Medical Device Investing Orchestra BioMed Receives FDA Breakthrough Device Designation for AVIM Therapy
Medical Device Investing Global AI Diagnostics Market to Reach $8.54 Billion By 2033 as Industry Sees Increasing R&D and Strategic Collaborations
Medical Device Investing Medtronic Evolut TAVR system shows durable clinical outcomes and outstanding valve performance at five years in low-risk aortic stenosis patients
Medical Device Investing Artificial Intelligence Influence on Healthcare Industry Reaching All Time Highs for Diagnostics and Treatments
Medical Device Investing Medtronic Announces FDA Approval of Infuse Bone Graft in New Spine Surgery Indications Using PEEK Interbody Implants
Medical Device Investing Medtronic Expands Visualase(TM) MRI-Guided Laser Ablation System to European Markets with CE Mark Approval
